Log in to save to my catalogue

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Intravenous immunoglobulin and Alzheimer’s disease: what now?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3720252

Intravenous immunoglobulin and Alzheimer’s disease: what now?

About this item

Full title

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Author / Creator

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2013-06, Vol.10 (1), p.70-70, Article 853

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Intravenous immunoglobulin (IVIG) products are prepared from purified plasma immunoglobulins from large numbers of healthy donors. Pilot studies with the IVIG preparations Octagam and Gammagard in individuals with mild-to-moderate Alzheimer's disease (AD) suggested stabilization of cognitive functioning in these patients, and a phase II trial with...

Alternative Titles

Full title

Intravenous immunoglobulin and Alzheimer’s disease: what now?

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3720252

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3720252

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/1742-2094-10-70

How to access this item